Treatment of EBV-Related Post-Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV-Specific T Cells
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (6) , 1415-1422
- https://doi.org/10.1111/j.1600-6143.2005.00854.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cellular immunotherapy for viral infections in solid organ transplant recipientsCurrent Opinion in Organ Transplantation, 2002
- Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restorationBlood, 2002
- Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipientsTransplantation, 2002
- Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cellsThe Lancet, 2002
- Management of Epstein–Barr Virus-induced Post-transplant Lymphoproliferative Disease in Recipients of Solid Organ TransplantationAmerican Journal of Transplantation, 2001
- EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERSTransplantation, 1999
- INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1Transplantation, 1998
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982